Bank Of Nova Scotia Neurocrine Biosciences Inc Transaction History

Bank Of Nova Scotia

  • $53.7 Billion
  • Q3 2025

A detailed history of Bank Of Nova Scotia transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 6,366 shares of NBIX stock, worth $922,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,366
Previous 5,235 21.6%
Holding current value
$922,178
Previous $657,000 35.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$123.98 - $146.67 $140,221 - $165,883
1,131 Added 21.6%
6,366 $893,000
Q2 2025

Aug 13, 2025
BUY
$87.54 - $128.18 $93,405 - $136,768
1,067 Added 25.6%
5,235 $657,000
Q1 2025

Jul 02, 2025
BUY
$107.22 - $153.29 $8,684 - $12,416
81 Added 1.98%
4,168 $460,000
Q1 2025

May 09, 2025
BUY
$107.22 - $153.29 $8,684 - $12,416
81 Added 1.98%
4,168 $460,000
Q4 2024

Jul 02, 2025
SELL
$111.62 - $139.44 $9,041 - $11,294
-81 Reduced 1.94%
4,087 $557,000
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $88,179 - $110,157
-790 Reduced 16.2%
4,087 $557,000
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $1.13 Million - $1.51 Million
-9,883 Reduced 66.96%
4,877 $561,000
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $983,282 - $1.08 Million
7,514 Added 103.7%
14,760 $2.03 Million
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $126,488 - $139,427
-970 Reduced 11.81%
7,246 $999,000
Q4 2023

Feb 12, 2024
BUY
$106.07 - $132.76 $189,334 - $236,976
1,785 Added 27.76%
8,216 $1.08 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $224,237 - $279,283
-2,385 Reduced 27.05%
6,431 $723,000
Q2 2023

Aug 03, 2023
SELL
$89.53 - $104.87 $10.6 Million - $12.5 Million
-118,734 Reduced 93.09%
8,816 $831,000
Q1 2023

May 11, 2023
SELL
$94.11 - $123.02 $1.2 Million - $1.57 Million
-12,768 Reduced 9.1%
127,550 $12.9 Million
Q4 2022

Feb 09, 2023
SELL
$106.72 - $127.06 $12.3 Million - $14.6 Million
-114,985 Reduced 45.04%
140,318 $16.8 Million
Q3 2022

Nov 10, 2022
BUY
$92.03 - $107.81 $22.4 Million - $26.3 Million
243,505 Added 2063.95%
255,303 $27.1 Million
Q2 2022

Aug 08, 2022
BUY
$75.79 - $100.07 $894,170 - $1.18 Million
11,798 New
11,798 $1.15 Million
Q2 2022

Aug 05, 2022
SELL
$75.79 - $100.07 $931,080 - $1.23 Million
-12,285 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$72.45 - $94.81 $398,619 - $521,644
5,502 Added 81.11%
12,285 $1.15 Million
Q4 2021

Feb 11, 2022
BUY
$79.65 - $106.22 $540,265 - $720,490
6,783 New
6,783 $578,000

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email